Listed by the USPTO as KASSA, TIGABU
Tech Center 1600 • Art Units: 1615 1619
This examiner grants 37% of resolved cases
Tigabu Kassa works in tech center 1600 and art unit 1615, with 725 resolved cases. The allowance rate is 36.7%, and the median time to allowance is 1562 days. Interview lift is 27.9%, indicating a favorable association between interviews and allowance outcomes in the available record.
The listed companies are ThermoLife International LLC, The Johns Hopkins University, and R.P. Scherer Technologies LLC. The listed firms are BOOTH UDALL, PLC, MICHAEL BEST & FRIEDRICH LLP (Mke), and OLIFF PLC. Practitioners may consider interviews as one component of a broader response strategy, while accounting for the extended median timing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17727123 | EFFERVESCENT ORAL COMPOSITION | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 17530559 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | Final Rejection | Boehringer Ingelheim International GmbH |
| 18315330 | BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION | Final Rejection | The Johns Hopkins University |
| 18187526 | CHEMICAL COMPOSITION | Non-Final OA | The Johns Hopkins University |
| 16851177 | BIOCOMPATIBLE ORGANOGEL MATRICES FOR INTRAOPERATIVE PREPARATION OF A DRUG DELIVERY DEPOT | Final Rejection | DePuy Synthes Products, Inc. |
| 16858439 | Coated Drug Compositions and Methods of Preparing the Same | Final Rejection | Applied Materials, Inc. |
| 18516295 | Softgel Capsule and Method of Marking a Softgel Capsule | Final Rejection | R.P. Scherer Technologies, LLC |
| 18208635 | ENTERIC BISACODYL SOFTGEL CAPSULE | Final Rejection | R.P. Scherer Technologies, LLC |
| 18867064 | CONCENTRATED CLEANSING COMPOSITIONS | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17293621 | SURFACTANT-STABILIZED FLUID INTERFACE AND DISPERSION COMPRISING ONE OR MORE DROPLETS HAVING A SURFACTANT STABILIZED FLUID INTERFACE | Final Rejection | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy36.7% of resolved applications examined by Tigabu Kassa were allowed (725 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +27.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Tigabu Kassa took 1,562 days on average from filing to allowance.
Tigabu Kassa examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
